Raquel E. Izumi - 07 Mar 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
President and Chief Operations Officer, Director
Signature
By: /s/ Raquel E. Izumi
Issuer symbol
VINC
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
08 Mar 2024, 20:08:22 UTC
Previous filing
10 Aug 2023
Next filing
29 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +123,750 $0.000000 123,750 07 Mar 2024 Common Stock 123,750 $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.

Remarks:

President and Chief Operations Officer